| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/25/2013 | CA2861428A1 Stabilization of the anti-cd20 antibody rituximab |
| 07/24/2013 | EP2618147A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
| 07/24/2013 | EP2617829A1 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium |
| 07/24/2013 | EP2617812A1 Composition for maintaining platelet function |
| 07/24/2013 | EP2617434A1 HIV-1 integrase deficient immunogens and methods for loading dendritic cells with said immunogens |
| 07/24/2013 | EP2617421A1 Tetrahydrofolates in combination with EGFR-inhibitors in the use of treating cancer |
| 07/24/2013 | EP2617413A2 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/24/2013 | EP2616812A1 Methods of treating autoimmune diseases with anti-fceri antibodies |
| 07/24/2013 | EP2616488A2 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid |
| 07/24/2013 | EP2616100A1 Compositions and methods for treatment of drug resistant multiple myeloma |
| 07/24/2013 | EP2616099A1 Immunogenic compositions |
| 07/24/2013 | EP2616098A2 A synthetic immunogen useful for generating long lasting immunity and protection against pathogens |
| 07/24/2013 | EP2616097A2 Vaccines against leptospira |
| 07/24/2013 | EP2616091A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph |
| 07/24/2013 | EP2616090A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph |
| 07/24/2013 | EP2616086A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
| 07/24/2013 | EP2616055A1 Compositions for treating cancer treatment - related fatigue |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1767854B Microfluidized oil-in-water emulsions and vaccine compositions |
| 07/24/2013 | CN103221825A Biomarkers and methods of treatment |
| 07/24/2013 | CN103221428A 4-1BB binding molecules |
| 07/24/2013 | CN103221427A Anti-OX40 antibodies and methods of using the same |
| 07/24/2013 | CN103221424A Recombinant T-cell receptor ligands with covalently bound peptides |
| 07/24/2013 | CN103221065A Hiv疫苗 Hiv Vaccine |
| 07/24/2013 | CN103221064A Immune methods against influenza viruses and combinatorial vaccines thereof |
| 07/24/2013 | CN103221063A High affinity human antibodies to human cytomegalovirus (CMV) gb protein |
| 07/24/2013 | CN103221062A Peripheral blood SPARC antibodies and uses thereof |
| 07/24/2013 | CN103221050A Combination of bevacizumab and 2,2-dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-N'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferative disorders |
| 07/24/2013 | CN103220921A Immunoadjuvant |
| 07/24/2013 | CN103215351A In vitro cancer therapy compound identification method |
| 07/24/2013 | CN103215302A Method for generating HPV18 L1 protein by using hansenula polymorpha expression system |
| 07/24/2013 | CN103215298A Recombinant expression vector for preparing anti-CSFV (Classical Swine Fever Virus) transgenic lactobacillus preparation |
| 07/24/2013 | CN103215274A Epinephelus coioides interferon IFNgamma2 and preparation method and application thereof |
| 07/24/2013 | CN103215236A Dust mite allergens Derf8 and Derf20, and genes and applications thereof |
| 07/24/2013 | CN103214582A Immunogenic fusion protein for tuberculosis and application of immunogenic fusion protein |
| 07/24/2013 | CN103214578A Novel humanized anti-CD22 antibody |
| 07/24/2013 | CN103214577A Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214570A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or Nl-subtype and uses thereof |
| 07/24/2013 | CN103214565A Dust mite allergens Derf24 and Derf25, and genes and applications thereof |
| 07/24/2013 | CN103214562A Attenuated enterotoxin C2 superantigen mutant protein as well as preparation method and application thereof |
| 07/24/2013 | CN103214560A Polypeptide used for preparing bovine foot and mouth disease type O peptide vaccine, and preparation method and application thereof |
| 07/24/2013 | CN103214556A Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MAT1 (Metastasis Associated Gene1) and application thereof |
| 07/24/2013 | CN103214554A Mucosal immunoadjuvant inducing Th1 immune response, and application thereof |
| 07/24/2013 | CN103212089A Preparation method and application of carbon nanomaterial-immunostimulatory sequence compound |
| 07/24/2013 | CN103212084A IgG FC fragment for a drug carrier and method for the preparation thereof |
| 07/24/2013 | CN103212075A Eye drop containing VEGF antagonist |
| 07/24/2013 | CN103212072A An antigen associated with lung cancers and lymphomas |
| 07/24/2013 | CN103212071A Stem cell fusion model of carcinogenesis |
| 07/24/2013 | CN103212070A Method for treating joint damage |
| 07/24/2013 | CN103212069A Immunologic adjuvant capable of improving antibody titer as well as preparation method and applications thereof |
| 07/24/2013 | CN103212068A Preparation method of chicken infectious bronchitis N-2-hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nano living vaccine |
| 07/24/2013 | CN103212067A Porcine contagious pleuropneumonia trivalent inactivated vaccine and its preparation method |
| 07/24/2013 | CN103212064A Application of phosphorylation-pathway-related factor in regulating regulatory T-cell function |
| 07/24/2013 | CN103212060A Application of protein and composition thereof in preparation of product used for preventing, diagnosing or treating EHEC (Enterohemorrhagic Escherichia Coli) infection |
| 07/24/2013 | CN102585004B AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity |
| 07/24/2013 | CN102533860B Foot and mouth disease vaccine and preparation method thereof |
| 07/24/2013 | CN102533677B Malaria vaccine and preparation method thereof |
| 07/24/2013 | CN102512686B Vaccine protectant, hydrophobia vaccine and preparation method thereof |
| 07/24/2013 | CN102471770B Antigen peptide and use thereof |
| 07/24/2013 | CN102258779B Sequential and repeated application of four or more HIV (human immunodeficiency virus) vector gene vaccines |
| 07/24/2013 | CN102218136B Anti-reovirus oral gene engineering vaccine and its preparation method |
| 07/24/2013 | CN102120773B Dual specificity antibodies and methods of making and using |
| 07/24/2013 | CN102002098B Modified flagellin and preparation method and use thereof |
| 07/24/2013 | CN101631563B Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 07/24/2013 | CN101454347B Influenza antigens, vaccine compositions, and related methods |
| 07/24/2013 | CN101437841B Virosome-like vesicles comprising gp41-derived antigens |
| 07/24/2013 | CN101370519B Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 07/23/2013 | USRE44389 Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies |
| 07/23/2013 | US8492532 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 07/23/2013 | US8492529 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus GB glycoprotein, and antigen-binding fragment thereof |
| 07/23/2013 | US8492527 Anti-VEGF antibodies |
| 07/23/2013 | US8492356 Methods of inhibiting tumor growth using TTK antagonists |
| 07/23/2013 | US8492119 Antibody to human IL-3 receptor alpha chain |
| 07/23/2013 | US8492103 Diagnosis and treatment of ehrlichiosis |
| 07/23/2013 | US8491918 Polypeptides from Neisseria meningitidis |
| 07/23/2013 | US8491917 Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the head |
| 07/23/2013 | US8491916 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 |
| 07/23/2013 | US8491915 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 07/23/2013 | US8491914 Dock-and-lock (DNL) complexes for delivery of interference RNA |
| 07/23/2013 | US8491913 Compositions and methods using recombinant MHC molecules for the treatment of stroke |
| 07/23/2013 | US8491912 Methods of treating ocular and other diseases with Syn-134R polypeptide |
| 07/23/2013 | US8491911 Pharmaceutical product for up-dosing of allergy vaccine |
| 07/23/2013 | US8491910 Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy |
| 07/23/2013 | US8491909 Methods and compositions for dosing of allergens |
| 07/23/2013 | US8491908 Composite particle, contrast agent for photoacoustic imaging, and method for producing the composite particle |
| 07/23/2013 | US8491907 Human anti-Pseudomonas-aeruginosa It-2 antibodies derived from transgenic xenomouse |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | US8491905 KLK-13 antibody inhibitor for treating dry eye |
| 07/23/2013 | US8491904 Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography |
| 07/23/2013 | US8491903 Method of treatment of neurodementing diseases using isolated, monoclonal, human, anti-B-amyloid antibody |
| 07/23/2013 | US8491902 Medicament comprising recombinant antibody against chemokine receptor CCR4 |
| 07/23/2013 | US8491901 Neutralizing anti-CCL20 antibodies |
| 07/23/2013 | US8491900 Antibodies to signal transduction protein TAB2 |
| 07/23/2013 | US8491899 Immunosuppressive polypeptides and nucleic acids |
| 07/23/2013 | US8491898 Monoclonal antibodies against CD30 lacking in fucosyl residues |
| 07/23/2013 | US8491897 Treatment of neuropathic pain using anti-thrombospondin antibodies |
| 07/23/2013 | US8491896 Anti-pancreatic cancer antibodies |
| 07/23/2013 | US8491895 Methods of treating cancer with human monoclonal antibodies to CTLA-4 |
| 07/23/2013 | US8491894 Method for inhibiting the growth of Mycobacterium tuberculosis by using CD13 receptor |